Short Interest in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Expands By 62.1%

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) was the recipient of a significant growth in short interest in the month of July. As of July 15th, there was short interest totalling 156,300 shares, a growth of 62.1% from the June 30th total of 96,400 shares. Based on an average daily trading volume, of 65,900 shares, the short-interest ratio is presently 2.4 days. Approximately 1.1% of the company’s shares are sold short.

Nature’s Sunshine Products Price Performance

NATR opened at $16.97 on Monday. The firm has a market cap of $317.85 million, a PE ratio of 19.96 and a beta of 0.87. The stock has a 50-day moving average price of $15.31 and a 200-day moving average price of $17.30. Nature’s Sunshine Products has a 1 year low of $13.36 and a 1 year high of $21.72. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.33 and a quick ratio of 1.42.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its earnings results on Tuesday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter. Nature’s Sunshine Products had a net margin of 3.69% and a return on equity of 10.59%. The business had revenue of $110.99 million during the quarter.

Insider Activity

In other Nature’s Sunshine Products news, EVP Bryant J. Yates sold 3,068 shares of the company’s stock in a transaction on Thursday, June 6th. The shares were sold at an average price of $15.30, for a total value of $46,940.40. Following the completion of the transaction, the executive vice president now directly owns 98,852 shares in the company, valued at approximately $1,512,435.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.70% of the company’s stock.

Hedge Funds Weigh In On Nature’s Sunshine Products

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NATR. Tower Research Capital LLC TRC boosted its holdings in shares of Nature’s Sunshine Products by 376.5% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,231 shares of the company’s stock valued at $73,000 after acquiring an additional 3,343 shares during the last quarter. Gladius Capital Management LP boosted its holdings in Nature’s Sunshine Products by 23.9% in the second quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock worth $103,000 after purchasing an additional 1,325 shares during the last quarter. SG Americas Securities LLC bought a new stake in Nature’s Sunshine Products in the 4th quarter worth approximately $125,000. Allspring Global Investments Holdings LLC purchased a new stake in Nature’s Sunshine Products during the 4th quarter valued at $139,000. Finally, Lazard Asset Management LLC boosted its stake in shares of Nature’s Sunshine Products by 16.5% in the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock worth $146,000 after buying an additional 998 shares during the last quarter. 79.40% of the stock is owned by institutional investors.

About Nature’s Sunshine Products

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.